Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Attenuation and protective efficacy of Rift Valley fever phlebovirus rMP12-GM50 strain.

Vaccine - 4 Dec 2017

Ly Hoai J, Nishiyama Shoko, Lokugamage Nandadeva, Smith Jennifer K, Zhang Lihong, Perez David, Juelich Terry L, Freiberg Alexander N, Ikegami Tetsuro

Abstract excerpt

Rift Valley fever (RVF) is a mosquito-borne zoonotic disease endemic to Africa and the Arabian Peninsula that affects sheep, cattle, goats, camels, and humans. Effective vaccination of susceptible ruminants is important for the prevention of RVF outbreaks. Live-attenuated RVF vaccines are in general highly immunogenic in ruminants, whereas residual virulence might be a concern for vulnerable populations. It is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Africa
Share to Neutralization Tests

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Reverse Genetics

Share to Vaccination

Share to Vaccines, Attenuated

Share to Vaccines, Synthetic

Share to Vero Cells

Share to Viral Vaccines

Source

Open in PubMed Open full text

Identifiers

PMID: 29061350
DOI: 10.1016/j.vaccine.2017.10.036
PMCID: PMC5696010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Attenuation and protective efficacy of Rift Valley fever phlebovirus rMP12-GM50 strain.PMID 29061350Read ↗

Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L SegmentsSemantic proximity Read ↗

Evaluations of rationally designed rift valley fever vaccine candidate RVax-1 in mosquito and rodent modelsSemantic proximity Read ↗

Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain.Semantic proximity Read ↗

Genetic subpopulations of Rift Valley fever virus strains ZH548 and MP-12 and recombinant MP-12 strains.Semantic proximity Read ↗

Rift Valley fever virus: Unanswered questions.Semantic proximity Read ↗

Distinct virulence of Rift Valley fever phlebovirus strains from different genetic lineages in a mouse modelSemantic proximity Read ↗

The Rift Valley fever (RVF) vaccine candidate 40Fp8 shows an extreme attenuation in IFNARKO mice following intranasal inoculationSemantic proximity Read ↗

Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine.Semantic proximity Read ↗

Safety and efficacy of four-segmented Rift Valley fever virus in young sheep, goats and cattleSemantic proximity Read ↗

Rapid accumulation of virulent rift valley Fever virus in mice from an attenuated virus carrying a single nucleotide substitution in the m RNA.Semantic proximity Read ↗

Comparative study of two Rift Valley fever virus field strains circulating in Mauritania in 2010 and 2013 reveals the high virulence of the MRU25010-30 strain isolated from camelSemantic proximity Read ↗

Molecular biology and genetic diversity of Rift Valley fever virus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.